Binetrakin

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBinetrakin
Drug Alias NameQuadrakineInterleukin-4 - DNAXSCH 39400Sch-39400
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-4 receptor subunit alpha agonists
TargetsInterleukin-4 receptor subunit alpha
Therapy Area/IndicationsInflammationImmunologic Deficiency SyndromesArthritis, Rheumatoid +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme Corp +[2] 
Active IndicationsN/A
Inactive IndicationsInflammationImmunologic Deficiency SyndromesArthritis, Rheumatoid +[6] 

Other Information

ATC CodeN/A
Related LinksN/A